Device Trial Radar · NCT07844681
Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Dec 30, 2028
Study completion Mar 30, 2029
Sponsor
- Lead sponsor
- University of MinnesotaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 28, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will compare surgical site infection after linear repair with or without cyanoacrylate skin adhesive following Mohs micrographic surgery or wide local excision. Adult participants undergoing Mohs micrographic surgery or wide local excision for skin cancer with a surgical defect suitable for linear repair will be stratified by suture type and randomized to standardized running epidermal suture closure with or without cyanoacrylate skin adhesive. The primary outcome is surgical site infection within 30 days after surgery. Secondary outcomes include scar quality, treatment satisfaction, wound care burden, wound healing characteristics, antibiotic use, culture results, health care utilization related to wound concerns, and adverse events.
Conditions
- Surgical Site Infection
- Skin Cancer
- Wound Healing
Interventions
Cyanoacrylate Skin AdhesiveDevice
Cyanoacrylate skin adhesive will be applied in a thin, continuous layer along the repaired wound after hemostasis and epidermal closure are complete. The adhesive is an FDA-approved topical wound closure product used within its labeled indication.
Fast Gut Running Epidermal Suture ClosureProcedure
Standardized running epidermal closure will be performed using fast gut absorbable suture material after Mohs micrographic surgery or wide local excision.
Vicryl Rapide Running Epidermal Suture ClosureProcedure
Standardized running epidermal closure will be performed using Vicryl Rapide absorbable suture material after Mohs micrographic surgery or wide local excision.
Prolene Running Epidermal Suture ClosureProcedure
Standardized running epidermal closure will be performed using Prolene non-absorbable suture material after Mohs micrographic surgery or wide local excision.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical Site Infection Within 30 Days After Linear RepairTime frame: Within 30 days after Mohs micrographic surgery or wide local excision
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Oxboro Dermatology Clinic
Minneapolis, Minnesota
University of Minnesota Dermatologic Surgery Clinic - CSC
Minneapolis, Minnesota
University of Minnesota Dermatologic Surgery Clinic - MG
Minneapolis, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.